Edison Oncology's Orotecan®: A Brighter Future For The Treatment of Recurrent Pediatric Cancers
The medication, Orotecan®, is a novel oral formulation of irinotecan, an intravenous drug that has demonstrated efficacy in treating various pediatric and adult cancers.